201 related articles for article (PubMed ID: 8599870)
21. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
Kolfschoten GM; Hulscher TM; Schrier SM; van Houten VM; Pinedo HM; Boven E
Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878
[TBL] [Abstract][Full Text] [Related]
22. Increased removal of DNA-bound platinum in a human ovarian cancer cell line resistant to cis-diamminedichloroplatinum(II).
Masuda H; Tanaka T; Matsuda H; Kusaba I
Cancer Res; 1990 Mar; 50(6):1863-6. PubMed ID: 2306738
[TBL] [Abstract][Full Text] [Related]
23. Anomalous relationship between cisplatin sensitivity and the formation and removal of platinum-DNA adducts in two human ovarian carcinoma cell lines in vitro.
Shellard SA; Hosking LK; Hill BT
Cancer Res; 1991 Sep; 51(17):4557-64. PubMed ID: 1873800
[TBL] [Abstract][Full Text] [Related]
24. Induction of apoptosis by a novel copper-based anticancer compound, casiopeina II, in L1210 murine leukaemia and CH1 human ovarian carcinoma cells.
De Vizcaya-Ruiz A; Rivero-Muller A; Ruiz-Ramirez L; Kass GE; Kelland LR; Orr RM; Dobrota M
Toxicol In Vitro; 2000 Feb; 14(1):1-5. PubMed ID: 10699355
[TBL] [Abstract][Full Text] [Related]
25. A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity.
Kelland LR; Barnard CF; Mellish KJ; Jones M; Goddard PM; Valenti M; Bryant A; Murrer BA; Harrap KR
Cancer Res; 1994 Nov; 54(21):5618-22. PubMed ID: 7923207
[TBL] [Abstract][Full Text] [Related]
26. Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression.
Supino R; Crosti M; Clerici M; Warlters A; Cleris L; Zunino F; Formelli F
Int J Cancer; 1996 Feb; 65(4):491-7. PubMed ID: 8621233
[TBL] [Abstract][Full Text] [Related]
27. N1,N12-bis(ethyl)spermine effect on growth of cis-diamminedichloroplatinum(II)-sensitive and -resistant human ovarian-carcinoma cell lines.
Marverti G; Piccinini G; Ghiaroni S; Barbieri D; Quaglino D; Moruzzi MS
Int J Cancer; 1998 Sep; 78(1):33-40. PubMed ID: 9724091
[TBL] [Abstract][Full Text] [Related]
28. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.
Judson PL; Watson JM; Gehrig PA; Fowler WC; Haskill JS
Cancer Res; 1999 May; 59(10):2425-32. PubMed ID: 10344753
[TBL] [Abstract][Full Text] [Related]
29. Characterization of acquired resistance to cis-diamminedichloroplatinum (II) in BE human colon carcinoma cells.
Fram RJ; Woda BA; Wilson JM; Robichaud N
Cancer Res; 1990 Jan; 50(1):72-7. PubMed ID: 2293559
[TBL] [Abstract][Full Text] [Related]
30. Cell cycle changes associated with formation of Pt-DNA adducts in human ovarian carcinoma cells with different cisplatin sensitivity.
Vaisman A; Varchenko M; Said I; Chaney SG
Cytometry; 1997 Jan; 27(1):54-64. PubMed ID: 9000585
[TBL] [Abstract][Full Text] [Related]
31. Cisplatin-induced apoptosis and p53 gene status in a cisplatin-resistant human ovarian carcinoma cell line.
Fajac A; Da Silva J; Ahomadegbe JC; Rateau JG; Bernaudin JF; Riou G; BĂ©nard J
Int J Cancer; 1996 Sep; 68(1):67-74. PubMed ID: 8895543
[TBL] [Abstract][Full Text] [Related]
32. [Cancer chemo-endocrine therapy and its cell biological basis].
Nishiya I
Hum Cell; 1998 Sep; 11(3):109-14. PubMed ID: 10086273
[TBL] [Abstract][Full Text] [Related]
33. Effects of a novel trinuclear platinum complex in cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines: interference with cell cycle progression and induction of apoptosis.
Orlandi L; Colella G; Bearzatto A; Abolafio G; Manzotti C; Daidone MG; Zaffaroni N
Eur J Cancer; 2001 Mar; 37(5):649-59. PubMed ID: 11290441
[TBL] [Abstract][Full Text] [Related]
34. Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) in A2780/S and A2780/PDD cells.
Han I; Ling YH; al-Baker S; Khokhar AR; Perez-Soler R
Cancer Res; 1993 Oct; 53(20):4913-9. PubMed ID: 8402681
[TBL] [Abstract][Full Text] [Related]
35. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
[TBL] [Abstract][Full Text] [Related]
36. Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues.
Behrens BC; Hamilton TC; Masuda H; Grotzinger KR; Whang-Peng J; Louie KG; Knutsen T; McKoy WM; Young RC; Ozols RF
Cancer Res; 1987 Jan; 47(2):414-8. PubMed ID: 3539322
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of drug resistance to the platinum complex ZD0473 in ovarian cancer cell lines.
Holford J; Beale PJ; Boxall FE; Sharp SY; Kelland LR
Eur J Cancer; 2000 Oct; 36(15):1984-90. PubMed ID: 11000581
[TBL] [Abstract][Full Text] [Related]
38. Induction of apoptosis in cisplatin-sensitive and -resistant human ovarian cancer cell lines.
Henkels KM; Turchi JJ
Cancer Res; 1997 Oct; 57(20):4488-92. PubMed ID: 9377558
[TBL] [Abstract][Full Text] [Related]
39. The significance of DNA cross-linking to cis-diamminedichloroplatinum(II)-induced cytotoxicity in sensitive and resistant lines of murine leukemia L1210 cells.
Strandberg MC; Bresnick E; Eastman A
Chem Biol Interact; 1982 Mar; 39(2):169-80. PubMed ID: 7199396
[TBL] [Abstract][Full Text] [Related]
40. Cell-cycle arrest, micronucleus formation, and cell death in growth inhibition of MCF-7 breast cancer cells by tamoxifen and cisplatin.
Otto AM; Paddenberg R; Schubert S; Mannherz HG
J Cancer Res Clin Oncol; 1996; 122(10):603-12. PubMed ID: 8879258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]